Anticoagulation and Non-urgent Commercial Air Travel: A Review of the Literature.
Department of Emergency Medicine, University of Virginia, Charlottesville, VA.
Brandon
B
Nunnally
Medical Department, Mondia Assistance-France, Paris, France.
Julien
J
Josseaume
Allianz Worldwide Partners, Paris, France.
Francois X
FX
Duchateau
University of Virginia, Charlottesville, VA; Allianz Global Assistance-US, Richmond, VA; Allianz Global Assistance-Canada, Kitchener, Ontario.
Robert E
RE
O'Connor
Allianz Worldwide Partners, Paris, France.
Laurent
L
Verner
University of Virginia, Charlottesville, VA. Electronic address: wb4z@virginia.edu.
William J
WJ
Brady
D000359:Aftercare; D064870:Air Travel; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D000069604:Dabigatran / Q000627:therapeutic use; D005593:Fracture Fixation, Internal; D006620:Hip Fractures / Q000601:surgery; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin; D000069604:Dabigatran